Merck Is a Candidate For a Dividend Reinvestment Portfolio

Merck & Company (MRK), a large pharmaceutical company, is on the price upside after making a double bottom. With its hefty dividend of 3.50 percent, Merck is a candidate for a long-term-dividend reinvestment portfolio.

Related Articles:

Double Bottom is a Bullish Pattern
Merck's Dividend Should be Safe for Now
Merck Has More Vioxx-Related Troubles
Merck Moves to the Upside

Posted December 27, 2006.

Home | Making Money | Portfolios | Dividends | Retirement | Articles | Charts | Stocks | Tables